Danthron as a novel IL-6R agonist promotes thrombopoiesis via the SRC/RAS/MAPK pathway
Danthron 作为一种新型 IL-6R 激动剂,可通过 SRC/RAS/MAPK 通路促进血小板生成。
期刊:Frontiers in Immunology
影响因子:
doi:10.3389/fimmu.2026.1730028
Liao, Rui; Luo, Jiesi; Li, Xiaoxuan; Tang, Xiaoqin; Huang, Miao; Zhou, Ling; Yun, Long; Liu, Zhixuan; Jiang, Peilian; Wang, Xinle; Gan, Xiaolin; Wang, Long; Wu, Jianming
血小板
信号转导
SRC
MAPK/ERK
RAS
IL-6